0001209191-20-025804.txt : 20200427
0001209191-20-025804.hdr.sgml : 20200427
20200427163909
ACCESSION NUMBER: 0001209191-20-025804
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200423
FILED AS OF DATE: 20200427
DATE AS OF CHANGE: 20200427
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heyman Richard A.
CENTRAL INDEX KEY: 0001584759
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39269
FILM NUMBER: 20820602
MAIL ADDRESS:
STREET 1: 5871 OBERLIN DRIVE, SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oric Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001796280
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 471787157
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 240 E. GRAND AVE.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 388-5600
MAIL ADDRESS:
STREET 1: 240 E. GRAND AVE.
STREET 2: 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-23
0
0001796280
Oric Pharmaceuticals, Inc.
ORIC
0001584759
Heyman Richard A.
C/O ORIC PHARMACEUTICALS, INC.
240 E. GRAND AVE., 2ND FLOOR
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (right to buy)
16.00
2020-04-23
4
A
0
16625
0.00
A
2030-04-22
Common Stock
16625
16625
D
100% of the shares subject to the option shall vest upon the earlier of (i) April 23, 2021 or (ii) the business day immediately preceding the Issuer's next annual stockholders' meeting.
/s/ Dominic Piscitelli, attorney-in-fact
2020-04-27